Biodesix Inc
NASDAQ:BDSX

Watchlist Manager
Biodesix Inc Logo
Biodesix Inc
NASDAQ:BDSX
Watchlist
Price: 1.45 USD 2.84% Market Closed
Updated: May 26, 2024

Biodesix Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biodesix Inc
Revenue Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Biodesix Inc
NASDAQ:BDSX
Revenue
$49.1m
CAGR 3-Years
3%
CAGR 5-Years
19%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Revenue
$12.3B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
0%
Quest Diagnostics Inc
NYSE:DGX
Revenue
$9.3B
CAGR 3-Years
-4%
CAGR 5-Years
4%
CAGR 10-Years
3%
CVS Health Corp
NYSE:CVS
Revenue
$360.9B
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
11%
Cigna Corp
NYSE:CI
Revenue
$206B
CAGR 3-Years
8%
CAGR 5-Years
22%
CAGR 10-Years
20%
Laboratory Corporation of America Holdings
NYSE:LH
Revenue
$12.3B
CAGR 3-Years
-7%
CAGR 5-Years
2%
CAGR 10-Years
8%

Biodesix Inc
Revenue Breakdown

Breakdown by Geography
Biodesix Inc

Not Available

Breakdown by Segments
Biodesix Inc

Total Revenue: 49.1m USD
100%
Diagnostic Tests: 45.2m USD
92.1%

See Also

What is Biodesix Inc's Revenue?
Revenue
49.1m USD

Based on the financial report for Dec 31, 2023, Biodesix Inc's Revenue amounts to 49.1m USD.

What is Biodesix Inc's Revenue growth rate?
Revenue CAGR 5Y
19%

Over the last year, the Revenue growth was 28%. The average annual Revenue growth rates for Biodesix Inc have been 3% over the past three years , 19% over the past five years .